Sign in with Google. Opens in new tab
bullish

Giant Biogene

Giant Biogene Placement - Great Track Record but Previous Deal Didn’t Do Well

444 Views16 Apr 2025 11:01
Giant Biogene (2367 HK) aims to raise up to US$250m via a top-up placement. In this note, we talk about the deal dynamics and run the deal through our ECM framework.
What is covered in the Full Insight:
  • Introduction
  • Deal Terms
  • Performance Analysis
  • Aequitas Deal Framework
  • Concluding Thoughts
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
x